Myeloperoxidase, modified lipoproteins, and atherogenesis.
about
Oxidative Stress Relevance in the Pathogenesis of the Rheumatoid Arthritis: A Systematic ReviewInflammation, plaque progression and vulnerability: evidence from intravascular ultrasound imaging3-nitrotyrosine modified proteins in atherosclerosisCardiolipin: characterization of distinct oxidized molecular speciesInhaled matters of the heartThe roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture.A Phytochemical-rich Multivitamin-multimineral Supplement Is Bioavailable and Reduces Serum Oxidized Low-density Lipoprotein, Myeloperoxidase, and Plasminogen Activator Inhibitor-1 in a Four-week Pilot trial of Healthy Individuals.Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasoundMyeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A(2)The biology of reactive intermediates in systemic lupus erythematosus.Oxidized high-density lipoprotein is associated with protein-energy wasting in maintenance hemodialysis patientsPlasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease.Kinetic studies on the reaction between dicyanocobinamide and hypochlorous acidMyeloperoxidase in human neutrophil host defence.Neutrophil-derived microparticles induce myeloperoxidase-mediated damage of vascular endothelial cells.Isoprostane generation and function.Diffused Intra-Oocyte Hydrogen Peroxide Activates Myeloperoxidase and Deteriorates Oocyte Quality.High Density Lipoprotein and it's DysfunctionPotent antioxidative activity of lycopene: A potential role in scavenging hypochlorous acidVascular peroxidase-1 is rapidly secreted, circulates in plasma, and supports dityrosine cross-linking reactions.Proconvertase proteolytic processing of an enzymatically active myeloperoxidase precursorTripping up Trp: Modification of protein tryptophan residues by reactive oxygen species, modes of detection, and biological consequencesIdentification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein InteractionRole of VPO1, a newly identified heme-containing peroxidase, in ox-LDL induced endothelial cell apoptosis.Usefulness of cardiac biomarker score for risk stratification in stable patients undergoing elective cardiac evaluation across glycemic status.The mitochondrial paradigm for cardiovascular disease susceptibility and cellular function: a complementary concept to Mendelian genetics.Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortiaSalivary biomarkers associated with myocardial necrosis: results from an alcohol septal ablation model.Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies.Why targeting HDL should work as a therapeutic tool, but has not.The reaction of HOCl and cyanocobalamin: corrin destruction and the liberation of cyanogen chloride.Effects of copper sulfate-oxidized or myeloperoxidase-modified LDL on lipid loading and programmed cell death in macrophages under hypoxia.VPO1 mediates oxidation of LDL and formation of foam cells.Myeloperoxidase acts as a source of free iron during steady-state catalysis by a feedback inhibitory pathway.Anti-myeloperoxidase antibodies attenuate the monocyte response to LPS and shape macrophage development.Potential for chlorine gas-induced injury in the extrapulmonary vasculature.Myeloperoxidase production by macrophage and risk of atherosclerosis.LDL apheresis and inflammation--implications for atherosclerosis.Role of phospholipid oxidation products in atherosclerosis.Molecular biology of atherosclerosis.
P2860
Q26747207-8E477048-A9AB-4289-9C74-B53CD178520DQ26786663-CA64C93F-8EF3-42ED-B4DA-9E1FB0755BDEQ28083260-48F16FA1-5B21-4896-A7DD-904526EDB921Q28385142-95199689-F034-4426-919A-C9B5530CF40FQ28395876-B08E36AF-E9E5-4B89-9319-8415D3F27F32Q30240734-BFD0C173-19CC-4932-8352-3B88E36DCA2CQ33570079-0F783451-6D0F-486A-91AC-96B699411D25Q33688005-64FD7A52-7B93-403C-B7AF-038D70F91A6AQ33741235-A170E001-142C-4266-8405-64D68F113B56Q33802441-3B65B9E0-D7EF-493C-BE7E-F345BEEB9C65Q33888423-B186E4CA-D5E3-4F59-81A9-1F015A7668BCQ34460370-49895D17-2E96-4F4E-B96C-4EFB4CC1345AQ34464974-CE0D8164-1761-445E-81C6-B508D737B9BDQ34994685-2A13227A-E614-49F0-ABA9-582D2F153BF6Q35185006-A59CE3B9-E1FD-4F2B-A75F-21E3E326AE8EQ35332267-B5A8CDE2-374C-47C2-81CA-F326ECDB713EQ35703310-D62B69C5-470A-4CFB-99A0-57FB4BEE788CQ36150462-65C3DD24-7ACD-4069-B060-829135972AC5Q36154620-EDA7CA96-D2D5-4185-89A6-14FF1E780FA2Q36228801-39CDD644-A656-4E89-BB30-C2257EEA127CQ36282271-45E73CBC-8203-4D5E-A6BE-86E712EE6243Q36386406-1FABBD63-E920-4BBB-B872-4B3A3DBF3252Q36489313-223BEB9F-8FEF-476B-9AC2-B09165290836Q36603272-5A02BA25-59A4-46AB-AA70-16945577A68FQ36810879-56D483D5-A882-45A1-9A7E-7F00489D2831Q36846068-3FBAF9E7-CA30-46C3-B1F1-93F23258FB04Q37045120-F950E989-720D-44DB-925C-2464E31AB1C0Q37076854-2733866D-A7B6-4117-9F00-0275EF1FB7B3Q37091275-F7859593-818F-4F14-A928-EC4B4C43C03EQ37170464-307A6B4E-CF4E-437A-957E-B98E6645453AQ37205406-D4E14DBB-A09E-4913-9374-93A9EEB84873Q37301032-C52A6752-ADB9-4949-9919-89909018371AQ37392502-ECC44B3C-AA4C-4F2E-9204-D68F1CF0B984Q37393355-D3057DAE-BA26-4EB8-8464-2D8A69BA38CFQ37599570-846E4C02-1729-407D-9F90-6F3225BACBEDQ37770003-E803F747-1717-4C38-A8F8-46ED2D4E0958Q37992526-6FB62D7A-FA9C-410F-8025-3574C036AFFCQ38016475-DEBFB72A-CB7A-41DA-8EF1-57AE4C25CBEAQ38039282-AD2A4C92-31EC-42B2-8453-491AE3190D77Q38125279-E34CDD95-3A0B-4FF1-A913-4F869831691A
P2860
Myeloperoxidase, modified lipoproteins, and atherogenesis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Myeloperoxidase, modified lipoproteins, and atherogenesis.
@en
Myeloperoxidase, modified lipoproteins, and atherogenesis.
@nl
type
label
Myeloperoxidase, modified lipoproteins, and atherogenesis.
@en
Myeloperoxidase, modified lipoproteins, and atherogenesis.
@nl
prefLabel
Myeloperoxidase, modified lipoproteins, and atherogenesis.
@en
Myeloperoxidase, modified lipoproteins, and atherogenesis.
@nl
P2860
P1476
Myeloperoxidase, modified lipoproteins, and atherogenesis.
@en
P2093
Stanley L Hazen
Stephen J Nicholls
P2860
P304
P356
10.1194/JLR.R800086-JLR200
P478
P577
2008-12-16T00:00:00Z